Clinical trials
Recruiting Parkinson Disease trials in the Netherlands
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
20 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2020 | 1 |
| 2021 | 1 |
| 2022 | 1 |
| 2023 | 2 |
| 2024 | 5 |
| 2025 | 7 |
| 2026 | 3 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Recruiting | 20 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Radboud University Medical Center | 6 |
| Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) | 3 |
| Vertero Therapeutics | 2 |
| AbbVie | 1 |
| Amsterdam UMC, location VUmc | 1 |
| GEN İlaç ve Sağlık Ürünleri A.Ş. | 1 |
| Maastricht University Medical Center | 1 |
| Michael J. Fox Foundation for Parkinson's Research | 1 |
| Prevail Therapeutics | 1 |
| Regeneron Pharmaceuticals | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Parkinson Disease | 20 |
| Neurodegenerative Diseases | 3 |
| Basal Ganglia Diseases | 2 |
| Brain Diseases | 2 |
| Central Nervous System Diseases | 2 |
| Disruptive, Impulse Control, and Conduct Disorders | 2 |
| Nervous System Diseases | 2 |
| Parkinsonian Disorders | 2 |
| Prodromal Symptoms | 2 |
| Synucleinopathies | 2 |
Trials
Showing 1 to 20 of 20. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.